| Donald E Barilla, MD | |
|
1243 S Cedar Crest Blvd, Suite 2800, Allentown, PA 18103-6268 | |
| (610) 402-6790 | |
| Not Available |
| Full Name | Donald E Barilla |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 1243 S Cedar Crest Blvd, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245201987 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | MD012578E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Donald E Barilla, MD Po Box 783311, Philadelphia, PA 19178-3311 Ph: () - | Donald E Barilla, MD 1243 S Cedar Crest Blvd, Suite 2800, Allentown, PA 18103-6268 Ph: (610) 402-6790 |
News Archive
Every March, most Americans welcome the switch to daylight saving time because of the longer days, but also dread losing an hour of sleep after they move their clocks forward. Now a new study shows that losing just an hour of sleep could pose some dangerous consequences for those in hazardous work environments.
Glioblastoma multiforme, a type of brain tumor, is one of the most difficult-to-treat cancers. Only a handful of drugs are approved to treat glioblastoma, and the median life expectancy for patients diagnosed with the disease is less than 15 months.
Cell Therapeutics, today announced that the Office of New Drugs of the U.S. Food and Drug Administration after carefully reviewing the materials CTI submitted in support of its appeal, the reviews of the New Drug Application for pixantrone prepared by the FDA staff, the transcript of the March 22, 2010 Oncology Drugs Advisory Committee meeting and consulting with the Center for Drug Evaluation and Research's Deputy Director of Clinical Science and the Office of Biostatistics, concluded that accelerated approval of pixantrone NDA 022481 may not necessarily be out of reach based on a single controlled clinical trial, provided two key matters can be satisfactorily resolved.
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.
› Verified 8 days ago
Jessica Mary Boehmler, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-439-8856 Fax: 610-439-8856 | |
Allison Jane Baragona, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1501 N Cedar Crest Blvd Ste 110, Allentown, PA 18104 Phone: 610-821-2828 Fax: 610-821-7915 | |
James A Burke, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 300, Allentown, PA 18103 Phone: 610-402-3110 Fax: 610-402-3112 | |
Stephen R Shore, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1901 Hamilton St Ste 300, Allentown, PA 18104 Phone: 610-628-7900 Fax: 833-816-7513 | |
Tarika Sejal Chowdhary, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 17th & Chew, Suite 101, Allentown, PA 18105 Phone: 610-969-4370 | |
Ashley Vojtek, DO Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 484-862-3200 | |
Dr. Ian William Klansek, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2490 Schoenersville Rd, Allentown, PA 18109 Phone: 484-526-7262 |